Teladoc

Teladoc

Preis: 7.31

Unternehmen und Geschäftsmodell

Teladoc Health, Inc. is a telehealth company that provides virtual healthcare services, including medical consultations, mental health support, and chronic condition management. Its core offerings encompass a range of telemedicine solutions, leveraging technology to connect patients with healthcare professionals. Major business segments include primary care, mental health, and specialty care services. The company generates revenue primarily through subscription fees and per-visit charges for its telehealth services.

Anlageprofil

The investment profile of Teladoc suggests it may be more aligned with growth investors, given its focus on expanding telehealth services in a rapidly evolving market. However, the current financial metrics indicate challenges, which may deter those seeking stable dividends or value opportunities. Investors should consider the potential for recovery against the backdrop of elevated risk factors.

Offizielle Website

Fundamentale Kennzahlen (experimentell)

EPS (TTM) — Gewinn pro Aktie der letzten 12 Monate, $
-0.97 Risiko
Umsatz QoQ — Umsatzwachstum im Quartalsvergleich
-4.4%
EPS-Überraschung
-5.5% schlechter als erwartet
20d Volatilität
4.1% stabil
FMP / FinFeed-Daten aktualisiert: 2026-06-11
Empf.: Verkaufen Potenzial: 30 Risiko: 69 Aktualisiert: 2026-06-11 05:26
Wie die Empfehlung funktioniert
Warum KI so denkt:
Weak fundamentals and negative momentum raise significant concerns.

Im Portfolio verfolgen

Preischart

KI-Empfehlung Analystenprognose Kalenderereignis Positives Signal Negatives Signal Neutral / Update Halten / informativ B My buy S My sell
Änderungen der AI-Empfehlung
Datum Vorher Nachher Grund
2026-06-09 02:52 Halten Verkaufen Weak fundamentals and negative momentum signal high risk.
2026-06-01 02:51 Verkaufen Halten Weak fundamentals and high risk limit upside potential.
2026-05-08 15:29 Verkaufen Weak fundamentals and high risk limit upside potential.
Analystenprognosen
Datum Analyst Action Ziel Preis damals
2026-04-08 13:16 Evercore ISI Ziel erhöht 5 → 6 5.27
2026-03-10 10:06 Deutsche Bank Aktualisieren — → 11 5.575
2026-02-26 13:20 Stifel Nicolaus Ziel gesenkt — → 6 5.07
Amazon CrowdStrike Nvidia Rivian Automotive Teladoc Novo Nordisk Gilead Sciences Qualcomm

Аналитики Bank of America понизили рейтинг Qualcomm (QCOM) до «недостаточно» из-за слабого роста, в то время как Nvidia (NVDA) остается в списке «покупать»

На Уолл-стрит в последние дни произошло несколько значительных изменений в рекомендациях аналитиков.